ORBIMED ADVISORS LLC – ARS Pharmaceuticals, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$46.15M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+24.53%
quarter
ARS Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 9.09M | $5.28 | 8.74M | |
| Q2 2022 | share | 0.00% | 0 shares | 6.38M | $4.24 | 8.74M | |
| Q1 2022 | share | 0.00% | 0 shares | -27.53M | $3.51 | 8.74M | |
| Q4 2021 | share | 0.00% | 0 shares | -29.02M | $6.6 | 8.74M | |
| Q3 2021 | share | 0.00% | 0 shares | -182.77M | $9.98 | 8.74M | |
| Q2 2021 | share | 0.00% | 0 shares | -111.35M | $30.89 | 8.74M | |
| Q1 2021 | share | 0.00% | 0 shares | -23.68M | $43.63 | 8.74M | |
| Q4 2020 | share | Increase | 0.00% | 8.74M shares | 405.05M | $46.34 | 8.74M |